These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 11297510)

  • 1. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.
    Zhu Y; Romero MI; Ghosh P; Ye Z; Charnay P; Rushing EJ; Marth JD; Parada LF
    Genes Dev; 2001 Apr; 15(7):859-76. PubMed ID: 11297510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.
    Bajenaru ML; Zhu Y; Hedrick NM; Donahoe J; Parada LF; Gutmann DH
    Mol Cell Biol; 2002 Jul; 22(14):5100-13. PubMed ID: 12077339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes.
    Kim HA; Rosenbaum T; Marchionni MA; Ratner N; DeClue JE
    Oncogene; 1995 Jul; 11(2):325-35. PubMed ID: 7624147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromin expression and astrogliosis in neurofibromatosis (type 1) brains.
    Nordlund ML; Rizvi TA; Brannan CI; Ratner N
    J Neuropathol Exp Neurol; 1995 Jul; 54(4):588-600. PubMed ID: 7602332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tie2-Cre-induced inactivation of a conditional mutant Nf1 allele in mouse results in a myeloproliferative disorder that models juvenile myelomonocytic leukemia.
    Gitler AD; Kong Y; Choi JK; Zhu Y; Pear WS; Epstein JA
    Pediatr Res; 2004 Apr; 55(4):581-4. PubMed ID: 14739366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulus-evoked release of neuropeptides is enhanced in sensory neurons from mice with a heterozygous mutation of the Nf1 gene.
    Hingtgen CM; Roy SL; Clapp DW
    Neuroscience; 2006; 137(2):637-45. PubMed ID: 16298082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 1: II. Answers from animal models.
    Lakkis MM; Tennekoon GI
    J Neurosci Res; 2001 Aug; 65(3):191-4. PubMed ID: 11494353
    [No Abstract]   [Full Text] [Related]  

  • 8. Nf1 has an essential role in endothelial cells.
    Gitler AD; Zhu Y; Ismat FA; Lu MM; Yamauchi Y; Parada LF; Epstein JA
    Nat Genet; 2003 Jan; 33(1):75-9. PubMed ID: 12469121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor.
    Rizvi TA; Akunuru S; de Courten-Myers G; Switzer RC; Nordlund ML; Ratner N
    Brain Res; 1999 Jan; 816(1):111-23. PubMed ID: 9878702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromin, the neurofibromatosis type 1 Ras-GAP, is required for appropriate P0 expression and myelination.
    Rosenbaum T; Kim HA; Boissy YL; Ling B; Ratner N
    Ann N Y Acad Sci; 1999 Sep; 883():203-14. PubMed ID: 10586246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
    Su W; Xing R; Guha A; Gutmann DH; Sherman LS
    Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner.
    Brown JA; Diggs-Andrews KA; Gianino SM; Gutmann DH
    Mol Cell Neurosci; 2012 Jan; 49(1):13-22. PubMed ID: 21903164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1.
    Jacks T; Shih TS; Schmitt EM; Bronson RT; Bernards A; Weinberg RA
    Nat Genet; 1994 Jul; 7(3):353-61. PubMed ID: 7920653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient delivery of Cre-recombinase to neurons in vivo and stable transduction of neurons using adeno-associated and lentiviral vectors.
    Ahmed BY; Chakravarthy S; Eggers R; Hermens WT; Zhang JY; Niclou SP; Levelt C; Sablitzky F; Anderson PN; Lieberman AR; Verhaagen J
    BMC Neurosci; 2004 Jan; 5():4. PubMed ID: 15005815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of melanocyte precursors in Nf1 mutants reveals that MGF/KIT signaling promotes directed cell migration independent of its function in cell survival.
    Wehrle-Haller B; Meller M; Weston JA
    Dev Biol; 2001 Apr; 232(2):471-83. PubMed ID: 11401406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice.
    Wu M; Wallace MR; Muir D
    J Neurosci Res; 2005 Nov; 82(3):357-67. PubMed ID: 16180234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues.
    Gutmann DH; Geist RT; Wright DE; Snider WD
    Cell Growth Differ; 1995 Mar; 6(3):315-23. PubMed ID: 7794799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
    Hattori S; Maekawa M; Nakamura S
    Oncogene; 1992 Mar; 7(3):481-5. PubMed ID: 1549362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation.
    Roth TM; Ramamurthy P; Ebisu F; Lisak RP; Bealmear BM; Barald KF
    Glia; 2007 Aug; 55(11):1123-33. PubMed ID: 17597122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.